Search results
Results from the WOW.Com Content Network
Rifampicin, also known as rifampin, is an ansamycin antibiotic used to treat several types of bacterial infections, including tuberculosis (TB), Mycobacterium avium complex, leprosy, and Legionnaires' disease. [3]
The Marada Movement (Arabic: تيار المردة, romanized: Tayyār Al-Marada) is a Lebanese political party and a former militia active during the Lebanese Civil War named after the legendary Marada (also called Mardaites) warriors of the early Middle Ages that fought on the external edge of the Byzantine Empire.
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]
1,3,6-Trigalloylglucose, or more specifically 1,3,6-Tri-O-galloyl-β-D-glucose, is a gallotannin. It can be found in Paeonia lactiflora and Terminalia chebula . [ 1 ]
[1] [2] It is one of the trimethoxyamphetamine (TMA) series of positional isomers. [1] [2] The drug is notable in being the amphetamine (i.e., α-methylated) analogue of mescaline (3,4,5-trimethoxyphenethylamine). [1] [2] TMA is said to be active at doses of 100 to 250 mg and to have a duration of 6 to 8 hours.
3,4-Methylenedioxyamphetamine (MDA) is an empathogen-entactogen, stimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug. [3] In its pharmacology , MDA is a serotonin–norepinephrine–dopamine releasing agent (SNDRA).
Rifapentine, sold under the brand name Priftin, is an antibiotic used in the treatment of tuberculosis. [2] In active tuberculosis it is used together with other antituberculosis medications. [2]
[159] [160] According to the WHO fifty one new therapeutic entities - antibiotics (including combinations), are in phase 1–3 clinical trials as of May 2017. [157] Antibiotics targeting multidrug-resistant Gram-positive pathogens remains a high priority. [161] [157] A few antibiotics have received marketing authorization in the last seven years.